Tc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal Adenocarcinoma - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2019

Tc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal Adenocarcinoma

Résumé

Mesothelin is a membrane-associated protein overexpressed in pancreatic ductal adenocarcinoma (PDAC). Some mesothelin-targeted therapies are in clinical development but the identification of patients eligible for such therapies is still challenging. The objective of this study was to perform the imaging of mesothelin in mice models of PDAC with a technetium-labeled anti-mesothelin single-domain antibody (Tc-A1).
Fichier principal
Vignette du fichier
cancers-11-01531-v2.pdf (1.28 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-02364601 , version 1 (07-07-2020)

Licence

Paternité

Identifiants

Citer

Christopher Montemagno, Shamir Cassim, Dimitry Trichanh, Clara Savary, Jacques Pouysségur, et al.. Tc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal Adenocarcinoma. Cancers, 2019, 11 (10), ⟨10.3390/cancers11101531⟩. ⟨hal-02364601⟩
39 Consultations
82 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More